Credo Technology Group Holding Ltd - Ordinary Shares (CRDO)

AI stocks like AMD, Micron, Credo, Cloudflare and AirJoule face a summer pullback, but intact spending trends and analyst price targets suggest their uptrends remain in place.

The CTO of Credo Technology executed the sale through a pre-arranged trading plan.

This insider maintains 3.1 million shares valued at $705 million after a sale under a Rule 10b5-1 trading plan.

This insider maintains 2.6 million shares directly and roughly 475,000 indirectly through a family trust after a planned sale under a Rule 10b5-1 trading arrangement.

Investors have favored domestic companies amid the increasingly uncertain geopolitical environment.

Cheng Chi Fung executed sales under a pre-arranged Rule 10b5-1 trading plan, retaining a $1.56 billion stake in the chipmaker.

Fabrinet, MACOM, and Credo posted strong AI-driven revenue growth and earn solid analyst Buy ratings, positioning them as overlooked plays within the semiconductor supply chain.

One offers explosive growth but carries customer concentration risk; the other brings scale and diversification.

Computing power is meaningless if chips can't work together.

Credo Technology Group (NASDAQ: CRDO) stock surges on Tuesday amid a broader technology sector rally and recent analyst upgrades. Read the market breakdown here.

Markets closed a shortened week higher as lower oil prices and a rally in chip stocks outweighed concerns about future Fed policy.

Credo Technologies is fast-becoming the standard in data center connectivity, providing zero-flap products spanning industry needs.

Networking player Credo is positioned to grow much faster than the semiconductor giants.

Explore how portfolio size, sector focus, and volatility set these growth ETFs apart for investors seeking different risk profiles and market exposures.

These two tickers are about to be the next AI headline stocks.

These AI infrastructure companies are poised to profit from the massive compute, networking, and data center build-out required to power Claude's next phase of growth.

Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.

Credo Technologies is gaining momentum and set up to succeed long-term as optics take center stage and design wins improve visibility.

We've seen this pattern before with Credo Technology stock.

Credo (CRDO) Q4 2026 Earnings Transcript